Combining Point-of-Care and HCP Programmatic in One Plan
How to plan point-of-care and NPI-matched programmatic together: shared lists, channel roles, frequency coordination, budget split, and joint measurement.
The short answer
Point-of-care and HCP programmatic work best as one plan with a shared target list, clear roles (programmatic for reach and education, point of care for reminders near decisions), coordinated frequency so top HCPs are not overloaded, a budget split based on cost per target reached, and one measurement design that can estimate each channel's contribution and their combined effect.
Point-of-care and programmatic are often planned by different people, bought from different vendors, and measured in separate studies that each claim credit for the same prescriptions. Planning them together fixes most of that.
Step 1: One target list
Use one NPI list with one set of tiers for every HCP channel. Ask each vendor to match it and report coverage. You will usually find:
- Programmatic reaches a large share of the list.
- Point of care reaches a smaller share, often concentrated in certain practice types.
- Some HCPs are reachable only through one channel.
Step 2: Give each channel a job
| Channel | Main job | Message type |
|---|---|---|
| NPI-matched programmatic | Reach and education | Core brand story, data highlights |
| Endemic | Depth in clinical context | Education, data |
| EHR and clinical apps | Reminder near decision | Patient selection, coverage, support |
| Waiting and exam room | Patient activation | Condition education, ask-your-doctor |
Step 3: Coordinate frequency
Set a combined frequency target by tier. Then:
- For HCPs heavily exposed at point of care, lower programmatic frequency.
- For HCPs not covered by point of care, raise programmatic weight.
- Review weekly using shared exposure data, where contracts allow.
Step 4: Split the budget
Use cost per target HCP reached and, where you have it, cost per incremental prescription. Hypothetical example:
| Channel | Target HCPs reachable | Cost per target reached | Budget share |
|---|---|---|---|
| Programmatic | 14,000 | Lower | 55% |
| EHR | 5,000 | Higher | 25% |
| Clinical app | 4,000 | Medium | 20% |
Point-of-care often costs more per HCP but may produce more value per exposure because of timing. Only outcome data can confirm that.
Step 5: Measure together
Design one study that compares HCPs exposed to:
- Programmatic only.
- Point of care only.
- Both.
- Neither (control).
This shows each channel's contribution and whether combining them adds more than either alone. Agree the design with your measurement partner before launch. See the measurement framework.
Sequencing
A simple sequence:
- Programmatic builds awareness across the list.
- Email and endemic add depth for engaged HCPs.
- Point of care reminds near decisions, focused on HCPs who have seen the core story.
The HCP media sequencing article explains how to use signals to move HCPs between channel jobs.
Common mistakes
- Separate lists per vendor.
- Each vendor running its own outcome study and claiming the same prescriptions.
- Equal frequency targets for HCPs regardless of point-of-care exposure.
- Budget split by habit.
Practical takeaway
At your next planning cycle, ask every HCP vendor for coverage on the same list and add the results to one table. The overlap and gaps it shows are the starting point for a coordinated plan.
Frequently asked questions
Should point-of-care and programmatic use the same target list?
Yes. A shared NPI list and tiers make coordination and measurement possible.
How do you avoid over-frequency across channels?
Share exposure data where allowed, set combined frequency goals by tier, and reduce programmatic frequency for HCPs who are heavily exposed at point of care.
How do you measure combined effect?
Compare groups exposed to each channel alone, both, and neither, using a control group design agreed before launch.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.